1. Home
  2. CEPL vs RPID Comparison

CEPL vs RPID Comparison

Compare CEPL & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capstone Energy Plus Inc. Common Stock

CEPL

Capstone Energy Plus Inc. Common Stock

HOLD

Current Price

$2.79

Market Cap

98.5M

Sector

Industrials

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$0.78

Market Cap

84.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CEPL
RPID
Founded
1988
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.5M
84.8M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
CEPL
RPID
Price
$2.79
$0.78
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
★ $16.50
$5.75
AVG Volume (30 Days)
★ 374.7K
184.6K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 2.78
EPS
★ N/A
N/A
Revenue
★ $106,004,000.00
$33,587,000.00
Revenue This Year
$2.85
$16.95
Revenue Next Year
$32.04
$17.92
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 23.89
19.74
52 Week Low
$2.55
$0.76
52 Week High
$12.32
$4.94

Technical Indicators

Market Signals
Indicator
CEPL
RPID
Relative Strength Index (RSI) 32.42 29.67
Support Level N/A $0.76
Resistance Level $6.85 $2.18
Average True Range (ATR) 0.35 0.05
MACD 0.05 0.02
Stochastic Oscillator 13.62 18.00

Price Performance

Historical Comparison
CEPL
RPID

About CEPL Capstone Energy Plus Inc. Common Stock

Capstone Energy+ Inc provides behind-the-meter clean energy solutions for industrial and commercial operations, as well as solutions for artificial intelligence (AI) and data center applications. It develops and manufactures oil-free, microturbine-based power generation systems designed to operate on a range of gaseous fuels.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: